Maintaining basal-bolus GLP-1 levels as a treatment approach These studies have clearly shown that MBS corrects post-prandial GLP-1 responses in people with obesity but does not improve fasting GLP-1 levels, which remain lower in some patients as compared to normal-weight individuals
ADHD and Women is the whole map the ADHD-Hormone Profile and what to do across every hormonal transition
Global, regional, and national burden of mortality and DALYs attributable to high body mass index from 1990 to 2021 with projections to 2036
Semaglutide has a high price because of a few reasons
The FDA declared the tirzepatide shortage resolved in 2025 and has since issued warning letters and enforcement actions against compounders and telehealth companies that marketed unauthorized or improperly compounded tirzepatide
Prescriptions for semaglutide and tirzepatide among patients with PCOS Between 2021 and 2025, 445,258 patients with PCOS had at least one medical encounter, of whom 90,206 (20.3%) received a semaglutide or tirzepatide prescription during the study period